These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1632308)

  • 1. Involvement of PAF in atherogenesis. Brief review.
    Koltai M; Braquet PG
    Agents Actions Suppl; 1992; 37():333-9. PubMed ID: 1632308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
    Koltai M; Pirotzky E; Braquet P
    Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
    Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
    Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions.
    Lupia E; Pucci A; Peasso P; Merlo M; Baron P; Zanini C; Del Sorbo L; Rizea-Savu S; Silvestro L; Forni M; Emanuelli G; Camussi G; Montrucchio G
    Int J Mol Med; 2003 Sep; 12(3):327-34. PubMed ID: 12883648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye].
    Cijevschi I; Cijevschi D
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):72-6. PubMed ID: 10756889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.
    Tokumura A; Sumida T; Toujima M; Kogure K; Fukuzawa K
    Biofactors; 2000; 13(1-4):29-33. PubMed ID: 11237195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cytokines and platelet-activating factor in renal pathology.
    Camussi G; Tetta C; Bussolino F; Andres G; Turello E; Baglioni C
    J Lipid Mediat; 1990; 2 Suppl():S203-13. PubMed ID: 2133283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.
    Evangelou AM
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jan; 50(1):1-28. PubMed ID: 8146205
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.
    Lundgren JD; Kaliner M; Logun C; Shelhamer JH
    Agents Actions; 1990 Jun; 30(3-4):329-37. PubMed ID: 2117336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I).
    Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
    Drugs; 1991 Jul; 42(1):9-29. PubMed ID: 1718687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelet-activating factor (PAF) in interstitial pulmonary disease.
    Martín T; Losa JE; García-Salgado MJ; Pérez-Arellano JL
    J Investig Allergol Clin Immunol; 1994; 4(3):149-57. PubMed ID: 7981886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.
    Braquet P; Paubert-Braquet M; Bourgain RH; Bussolino F; Hosford D
    J Lipid Mediat; 1989; 1(2):75-112. PubMed ID: 2519889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
    Graham RM; Strahan ME; Norman KW; Watkins DN; Sturm MJ; Taylor RR
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor: receptors and signal transduction.
    Chao W; Olson MS
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):617-29. PubMed ID: 8391253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain.
    Park TS; Gonzales ER; Gidday JM
    J Cereb Blood Flow Metab; 1999 Apr; 19(4):417-24. PubMed ID: 10197511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis.
    Dentan C; Lesnik P; Chapman MJ; Ninio E
    Eur J Biochem; 1996 Feb; 236(1):48-55. PubMed ID: 8617285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.
    Bartemes KR; McKinney S; Gleich GJ; Kita H
    J Immunol; 1999 Mar; 162(5):2982-9. PubMed ID: 10072549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
    Zatta A; Zanetti A; Dejana E; Prosdocimi M
    Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for platelet-activating factor in asthma.
    Chung KF; Barnes PJ
    Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.